Central Venous Catheters Market Report 2026

Central Venous Catheters Market Overview

• Central Venous Catheters market size has reached to $4.3 billion in 2025 • Expected to grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Impact of Increasing Kidney Disease Cases on the Central Venous Catheter Market • Market Trend: Technological Advancements in the Central Venous Catheter Market: Focus on Advanced Ultrasound Systems • North America was the largest region in 2025.

What Is Covered Under Central Venous Catheters Market?

Central venous catheters (CVCs) are medical devices inserted into large veins for long-term intravenous therapy, medication administration, and blood draws. They enable rapid treatment delivery, reduce the need for repeated needle sticks, and allow for critical patient monitoring, making them essential for complex medical care. The main types in the central venous catheters market are single-lumen, double-lumen, triple-lumen, and others. Single-lumen central venous catheters are medical devices with a single channel inserted into a large vein to deliver medications, fluids, or nutrients directly into the bloodstream. The various properties include antimicrobial coated and non-antimicrobial coated, and several applications including jugular vein, subclavian vein, femoral vein, and others. The different end users encompass hospitals, ambulatory surgical centers, and others.

What Is The Central Venous Catheters Market Growth Forecast?

The central venous catheters market size is expected to see strong growth in the next few years. It will grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing focus on hospital-acquired infection reduction, rising adoption of advanced catheter materials, expansion of outpatient infusion services, growing demand for safer vascular access devices, increasing investments in patient safety technologies. Major trends in the forecast period include increasing use of antimicrobial-coated catheters, growing adoption of multi-lumen catheter designs, rising focus on infection prevention protocols, expansion of long-term vascular access solutions, enhanced training for catheter placement procedures.

What Is The Driver Of The Central Venous Catheters Market?

The rising cases of kidney diseases is expected to propel the growth of the central venous catheter market going forward. The increasing incidence of kidney diseases is driven by factors such as rising rates of chronic conditions such as diabetes and hypertension, which require interventions such as central venous catheters for essential treatments such as dialysis. Central venous catheters assist in managing kidney diseases by providing essential access to hemodialysis, medication administration, nutritional support, and frequent blood draws. For instance, in June 2023, according to Kidney Research UK, a UK-based charity, the prevalence of kidney disease in the UK is estimated to affect 7.19 million people in 2023, more than 10% of the population. It is expected to reach 7.61 million by 2033, with the proportion of patients in later stages of the disease increasing from 45% to 51%. Therefore, rising cases of kidney diseases will drive the central venous catheter industry.

Key Players In The Global Central Venous Catheters Market

Major companies operating in the central venous catheters market are Medtronic plc, Becton, Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Group Incorporated, ICU Medical Inc., Lepu Medical Technology (Beijing) Co. Ltd, Merit Medical Systems Inc, Vygon SAS, AngioDynamics Inc., Argon Medical Devices Inc., Poly Medicure Limited, Vogt Medical Vertrieb GmbH, MedCath Corporation, GaltNeedleTech Inc., Romsons International, Newtech Medical Devices Private Limited, NIPRO Medical Corporation, DemeTECH Corporation, Scitech Medical Products SA, Prodimed, P. K. Scientific & Chemicals

Global Central Venous Catheters Market Trends and Insights

Major companies operating in the central venous catheter market are developing advanced ultrasound systems to enhance precision and safety during catheter insertion procedures. Advanced ultrasound systems improve central venous catheter placement by providing real-time visualization, increasing accuracy, reducing complications, and improving patient comfort and procedural efficiency. For instance, in November 2023, Becton, Dickinson, and Company (BD), a US-based medical technology company, launched SiteRite 9, an advanced vascular access ultrasound system to improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices. The SiteRite 9 ultrasound system features a user-friendly 15.6-inch touchscreen with enhanced image quality. It includes the Cue needle tracking system for real-time needle tracking and the Sherlock 3CG+ tip confirmation system for precise catheter navigation. BD's advanced ultrasound technology aims to simplify vascular access procedures, supporting clinician efficiency with intelligent, connected features such as vessel assessment and automated data capture.

What Are Latest Mergers And Acquisitions In The Central Venous Catheters Market?

In September 2024, Becton, Dickinson and Company, a US-based medical technology company, completed the acquisition of Critical Care from Edwards Lifesciences for an undisclosed amount. Through this acquisition, BD aims to expand its smart connected care portfolio, strengthen its position in high-growth monitoring technologies, and enhance its offerings in advanced hemodynamic monitoring solutions used in intensive care and surgical settings. Critical Care, a division of Edwards Lifesciences, is a US-based provider of advanced patient monitoring systems, including central venous catheters.

What Defines the Central Venous Catheters Market?

The central venous catheters market consists of sales of standard CVCs, peripherally inserted central catheters (PICCs), implantable ports, and specialty CVCs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Central Venous Catheters Market Report 2026?

The central venous catheters market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the central venous catheters industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.